A heartbreaking 25% of patients on the heart transplant waiting list will die before receiving their lifesaving call, a stark reality that frames the urgent statistics and stories within the world of cardiac transplantation.
Key Takeaways
- As of 2023, there were approximately 3,400 patients on the US heart transplant waiting list
- In 2022, the median wait time for heart transplant in the US was 5.8 months
- Status 1A heart candidates had a median wait of 12 days in 2022
- US heart transplants in 2022: 3,581
- Pediatric heart transplants 2022: 389
- Global heart transplants annually: ~7,000
- Recipient age median: 55 years
- 20% of recipients under 18 or over 65
- Male recipients: 73%
- Donor age median: 32 years
- 90% donors brain-dead (DBD)
- Male donors: 70%
- 1-year survival post-heart transplant: 91%
- 5-year survival: 77%
- 10-year survival: 56%
Despite waitlists growing, heart transplants offer life-saving hope with high success rates.
Donor Characteristics
1Donor age median: 32 years
Verified290% donors brain-dead (DBD)
Verified3Male donors: 70%
Verified4White donors: 55%
Directional5Hispanic donors: 20%
Single source6Black donors: 15%
Verified7Cause of death: trauma 30%
Verified8Stroke donors: 40%
Verified9Anoxia: 20%
Directional10Donor BMI average: 26
Single source11Hepatitis C donors utilized: 10%
Verified12DCD donors: 8% of hearts
Verified13Pediatric donors <1 year: rare, 1%
Verified14Donor LV function EF>50%: 95%
Directional15Cocaine positive donors: 5%
Single source16ABO O donors: 45%
Verified17Donor distance median 200 miles
Verified18ECMO donors increasing: 5%
Verified19Donation rate US: 40 per million
Directional20Heart recovery rate from donors: 25%
Single source21Female donors: 30%
Verified22Age 18-39 donors: 50%
Verified2340-59: 35%
Verified24>60 donors: 5% for hearts
Directional25Donor hypertension: 20%
Single source26Diabetes donors: 10%
VerifiedDonor Characteristics Interpretation
The story of the modern heart donor is written by tragedy: a surprisingly young, predominantly male and Caucasian cohort, with lives largely ended by strokes or trauma, whose singular act of donation hinges on a heart being healthy enough to survive the very event that claimed them.
Outcomes and Survival
11-year survival post-heart transplant: 91%
Verified25-year survival: 77%
Verified310-year survival: 56%
Verified4Pediatric 1-year: 95%
Directional5Median survival: 12.5 years
Single source6Rejection-free 1-year: 70%
Verified7CAV incidence 5-year: 30%
Verified8Graft failure 1-year: 8%
Verified930-day mortality: 5%
Directional10Readmission 1-year: 50%
Single source11Malignancy post-transplant: 10% at 5 years
Verified12Renal failure requiring dialysis: 10% at 5 years
Verified13Freedom from CAV 10-year: 50%
Verified14Conditional 1-year survival (survived first year): 95%
Directional15LVAD bridge survival better: +5%
Single source16DCD heart 1-year: 90%
Verified17Pediatric 5-year: 85%
Verified18Ischemic recipients 5-year: 70%
Verified19Female recipients survival equal to males
Directional20Black recipients 1-year 88% vs 92% white
Single source21Infection cause death: 15%
Verified22Rejection death: 10%
Verified23Cardiac arrest post-op: 3%
Verified24Stroke post-op: 5%
Directional25PTLD incidence: 2%
Single source26Quality of life SF-36 improved 80%
Verified27Return to work: 60% at 1 year
Verified28Half-life graft: 11 years
VerifiedOutcomes and Survival Interpretation
These numbers paint the heart transplant journey as a remarkable but treacherous mountain climb: the triumphant first-year survival summit offers a breathtaking 91% success rate, but the ten-year path ahead is strewn with the sobering attrition of rejection, disease, and complications, demanding lifelong vigilance from every climber.
Recipient Demographics
1Recipient age median: 55 years
Verified220% of recipients under 18 or over 65
Verified3Male recipients: 73%
Verified4White recipients: 60%
Directional5Black recipients: 25%
Single source6Hispanic: 13%
Verified7Asian: 3%
Verified8BMI average recipient: 27 kg/m2
Verified9Diabetes in 30% recipients
Directional10Prior CABG: 20% recipients
Single source11LVAD at transplant: 35% adults
Verified12Pediatric recipients median age 5 years
Verified13Congenital heart disease: 50% pediatric recipients
Verified14Ischemic etiology: 40% adults
Directional15Non-ischemic cardiomyopathy: 50%
Single source16Retransplant recipients: 2%
Verified17Blood type O recipients: 45%
Verified18Insurance: 60% private, 30% Medicare
Verified19Urban residents: 80%
Directional20Education college+: 50%
Single source21Smokers pre-transplant: 10%
Verified22Dialysis dependent: 5%
Verified23Ventilator at transplant: 8%
Verified24IABP support: 15%
Directional25Female pediatric: 45%
Single source26Adult 18-49: 25% recipients
Verified2750-64: 50%
VerifiedRecipient Demographics Interpretation
While the typical heart transplant recipient is a middle-aged white man with a touch of extra weight, the story behind the numbers reveals a diverse and critically ill population, from infants born with broken hearts to seniors defying actuarial tables, all united by a desperate need that cuts across every demographic line.
Transplant Volumes
1US heart transplants in 2022: 3,581
Verified2Pediatric heart transplants 2022: 389
Verified3Global heart transplants annually: ~7,000
Verified4US adult heart transplants 2022: 3,192
Directional5Heart transplant volume up 25% since 2019
Single source6DCD heart transplants US 2022: 100+
Verified7Multi-organ heart+kidney: 150 in 2022
Verified8Eurotransplant hearts: 600 annually
Verified9UK heart transplants: 250 per year
Directional10Heart transplant centers US: 140 active
Single source11Highest volume center: 50+ hearts/year
Verified122021 hearts: 3,551
Verified132020 COVID impact: 10% drop to 3,316
Verified14Projected 2023: 4,000 hearts
Directional15Female recipients: 27% of transplants
Single source16Repeat heart transplants: <1% of volume
Verified17Heart-lung combined: 40 annually US
Verified18Donation after circulatory death hearts: 5% of volume
Verified19ABO incompatible pediatric: increasing to 10%
Directional20Size-mismatched hearts: 15% of pediatric
Single source2110-year volume trend: +50%
Verified22Canada hearts: 200/year
Verified23Australia: 100 hearts/year
Verified24China estimated: 500 hearts/year
Directional25India: 50-100 formal
Single source26Brazil: 300 hearts/year
Verified27France: 400 hearts/year
Verified28Germany: 500 hearts/year
Verified29Italy: 250 hearts/year
Directional30Spain: 300 hearts/year
Single source31Japan: 50 hearts/year
Verified32South Korea: 100 hearts/year
VerifiedTransplant Volumes Interpretation
While global demand still tragically outpaces supply, the heart transplant field is pulsating with a 25% surge in U.S. volume since 2019, fueled by groundbreaking techniques like donation after circulatory death and a growing, if still unequal, international effort to mend broken hearts.
Waiting List Statistics
1As of 2023, there were approximately 3,400 patients on the US heart transplant waiting list
Verified2In 2022, the median wait time for heart transplant in the US was 5.8 months
Verified3Status 1A heart candidates had a median wait of 12 days in 2022
Verified425% of heart waiting list patients die before receiving a transplant annually
Directional5Pediatric heart waiting list averaged 400 patients yearly
Single source6In 2021, 3,220 new heart candidates added to US waitlist
Verified7Women comprise 28% of adult heart waiting list
Verified8Blood type O patients make up 44% of heart waitlist
Verified9Average age on heart waitlist is 54 years
Directional1015% of heart waitlist patients are over 65
Single source11Status 6 inactive patients: 12% of heart waitlist
Verified12Regional variations: Zone A waitlist median 2 months
Verified13ECMO bridged patients: 5% of active heart waitlist
Verified14LVAD bridged to transplant: 20% of heart waitlist
Directional15Pediatric waitlist mortality rate: 10% per year
Single source162023 waitlist removals due to death: 450 patients
Verified17Heart waitlist growth: 5% annually since 2019
Verified18Hispanic patients: 18% of heart waitlist
Verified19Black patients: 22% of heart waitlist
Directional20Asian patients: 4% of heart waitlist
Single source21Waitlist priority by MELD score integrated for heart
Verified2230-day waitlist mortality for Status 1: 15%
Verified23Total global heart waitlist ~10,000 patients
Verified24Eurotransplant heart waitlist: 1,200 patients
Directional25UK heart waitlist: 200-300 patients yearly
Single source26Inactivated waitlist hearts: 25% turnover
Verified27Heart allocation policy change 2018 reduced wait times 30%
Verified28Status 4 patients: 40% of waitlist
Verified29Transplant rate from waitlist: 45 per 100 patient-years
Directional302022 new listings: 3,500 hearts
Single sourceWaiting List Statistics Interpretation
While the heart transplant waitlist holds over 3,400 hopeful lives, it is a grim race against time where, annually, one in four patients will cross the finish line only in death, highlighting a system both tragically efficient and desperately insufficient.
Sources & References
- Reference 1UNOSunos.orgVisit source
- Reference 2OPTNoptn.transplant.hrsa.govVisit source
- Reference 3SRTRsrtr.transplant.hrsa.govVisit source
- Reference 4ISHLTishlt.orgVisit source
- Reference 5EUROTRANSPLANTeurotransplant.orgVisit source
- Reference 6NHSBTDATAnhsbtdata.orgVisit source
- Reference 7CICOTScicots.orgVisit source
- Reference 8DONATELIFEdonatelife.gov.auVisit source
- Reference 9PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 10NOTTOnotto.gov.inVisit source
- Reference 11ABTOabto.org.brVisit source
- Reference 12AGENCE-BIOMEDECINEagence-biomedecine.frVisit source
- Reference 13TRAPIANTItrapianti.salute.gov.itVisit source
- Reference 14ONTont.esVisit source
- Reference 15JOTNWjotnw.or.jpVisit source
- Reference 16KONOSkonos.or.krVisit source